Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

NCT01478971 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Anemia

Interventions

DRUG: Epoetin
DRUG: Peginesatide

Sponsor

Takeda

Collaborators

[object Object]